Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
Subscribe
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision
Online Early
Online Early
Current Issue
Current Issue
Core Evidence
Vol. 2, No. 4
July, 2008
ISSN: 1555-1741
Free Trial
Free Trial
Sample Sample
Editorial
Editor-in-Chief
  Paul Chrisp, PhD
Editor, North America
  Doris Peter, PhD
Consultant Editor
  Stephen R. Chapman, PhD
International editorial board
  Darren M. Ashcroft, PhD, University of Manchester, Manchester, UK
  Henry R. Black, MD, Rush University Medical Center, Chicago, IL, USA
  G. Walter Canonica, MD, University of Genoa, Genoa, Italy
  Joshua P. Cohen, PhD, Tufts Center for the Study of Drug Development, Boston, MA, USA
  Sharon Conroy, BPharm, Derbyshire Children’s Hospital, Derby, UK
  Sanford I. Finkel, MD, University of Chicago Medical School, Chicago, IL, USA
  John A. Glaspy, MD, UCLA School of Medicine, Los Angeles, CA, USA
  Abraham G. Hartzema, PharmD, University of Florida, Gainesville, FL, USA
  Joel W. Hay, PhD, University of Southern California, Los Angeles, CA, USA
  David M. Herrington, MD, Wake Forest University School of Medicine, Winston-Salem, NC, USA
  Stephen T. Holgate, MD, Southampton General Hospital, Southampton, UK
  Philip D. Home, DM, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
  Martin Knapp, PhD, London School of Economics and Political Science, London, UK
  Andrew J. Krentz, MD, Southampton General Hospital, Southampton, UK
  Paul C. Langley, PhD, University of Minnesota, Minneapolis, MN, USA
  Peter G.M. Mol, PhD, University Medical Center Groningen, Groningen, the Netherlands
  Robert P. Navarro, PharmD, Campbell Alliance, Raleigh, NC, USA
  Donal J. O'Donoghue, MD, Hope Hospital, Manchester, UK
  Olivier Rascol, MD, Toulouse University Hospital, Toulouse, France
  Emilio J. Sanz, MD, University of La Laguna School of Medicine, La Laguna, Tenerife, Spain
  David L. Scott, MD, King’s College Hospital, London, UK
  Ya-Chen Tina Shih, PhD, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
  Dominic A. Sica, MD, Virginia Commonwealth University, Richmond, VA, USA
  Andy Stergachis, PhD, University of Washington, Seattle, WA, USA
  Sean D. Sullivan, PhD, University of Washington, Seattle, WA, USA
  Nicholas J. Talley, MD, Mayo Clinic, Rochester, MN, USA
  Alan D. Tice, MD, John A. Burns School of Medicine, Honolulu, HI, USA
  Tom Walley, MD, University of Liverpool, Liverpool, UK
  Myron H. Weinberger, MD, Indiana University School of Medicine, Indianapolis, IN, USA
  Alberto Zanchetti, MD, University of Milan, Milan, Italy
Peer reviewed
The editorial process combines clearly defined drug selection criteria, evidence-based medicine techniques, and expert clinical opinion, written in a format based on formulary requirements
Core Evidence is included in EMBASE, EMNursing, Scopus, the Health Economic Evaluations Database (HEED), and CINAHL. Indexing in all other major databases is being applied for